Vinva Investment Management LTD Exact Sciences Corp Transaction History

Vinva Investment Management LTD

  • $2.37 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$59.06 - $75.72 $967,461 - $1.24 Million
-16,381 Reduced 69.88%
7,061 $535 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $611,923 - $919,091
9,280 Added 65.53%
23,442 $1.62 Billion
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $887,674 - $1.35 Million
14,162 New
14,162 $1.34 Billion

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Vinva Investment Management LTD Portfolio

Follow Vinva Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vinva Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vinva Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email